含糖聚合物的研究现状与进展

综述了含糖乙烯基单体的合成、含糖聚合物的"活性"/可控自由聚合以及含糖聚合物在生物医药领域中的应用.含糖聚合物因其优良的生物相容性、亲水性和靶向性等功能,赋予含糖聚合物作为智能人造材料尤其在生物和生物医药等领域具有各种特殊用途,今后含糖聚合物的研究将集中于含糖聚合物的结构控制以及聚合物的实际应用性能的开发上.     

Exact inference for two exponential populations with competing risks data

In a reliability comparative test, the joint censoring model is usually adopted to evaluate the performances of units with the same facility. However, most researchers ignore the pos- sibility that there is more than one factor for the failure when a test unit fails. To solve this problem, we consider a joint Type-II hybrid censoring model for the analysis of exponential competing failure data. Based on the maximum likelihood theory, we compute the maximum likelihood estimators （MLEs） of parameters and then obtain the condition ensuring MLEs existence for every unknown parameter. Then we derive the conditional exact distributions and corresponding moment properties for parameters by the moment generating function （MGF）. A Monte-Carlo simulation is conducted to compare the performances of different ways. And finally, we conduct a numerical example to illustrate the proposed method.     

循环网络模拟技术在土石方工程中的应用

土石方工程由于施工过程的复杂及受到众多随机因素的影响,很难用人工方法精确计算各道路的行车及排队情况,确定各道路的等级以及施工机械设备的数量。采用循环网络模拟技术,用挖、装、运、卸等仿真节点来模拟实际施工的相应过程,建立能反映土石方实际开挖过程的仿真模型。仿真得出的一系列施工参数为辅助管理人员做出决策提供参考依据。某工程中的成功应用表明,此方法快捷、便利,值得深入研究并推广应用。     

太阳电池填充因子随日照强度变化的理论分析与计算

根据太阳电池直流模型和最大功率点数学条件,推出短路电流、开路电压、最大功率点电流和电压 以及填充因子随日照强度变化的数学关系式;并选取２个电池分别计算出在不同日照强度下上述电池参数随日 照强度的变化率。验证了短路电流和最大功率点电流是近似跟日照强度成正比,开路电压和最大功率点电压是 近似跟日照强度的自然对数成正比。并提出了填充因子随日照强度的变化关系不具有简单的函数形式,而对不 同的太阳电池其变化关系也迥异。最后用Multisim的模拟结果检验了理论分析计算的正确性。     

基于智能体模拟的结构性疏散计划设计研究

展示了一个基于Agent模拟方法的框架方法,用于为危急中的复杂技术系统设计结构性的疏散计划.该计划利用复杂自适应系统的模拟方式,并采用基于智能体模拟的方法作为认知工具来设计整体系统的疏散方案.结构化的疏散计划应用文中提出的整体性技术框架,没有采用标准化的常规方法.提出了一个使疏散人群能够更加适应的调整危机时刻的紧急情况和减少无效疏散的建议性方案.本框架方法在一个典型的复杂自适应系统一地铁火灾中得到应用.     

三维地学建模技术与Kriging方法在固体矿产储量计算中的应用

结合Kriging方法在计算机上的实现和应用,介绍了运用三维地学建模技术生成矿体的三维品位模型的原理流程以及关键技术,并在此基础上进行矿产资源储最计算.其基本流程为:根据实际地质勘探数据生成矿体三维实体模型;在实体tin模型内部应用块模型方法进行划分,建立矿体块体模型;利用Kriging方法进行插值,生成矿体的品位模型...     

施工企业防范经营风险初探

施工企业经营风险是指企业在经营中对未来经营环境中的不确定因素与多变性无法全部或精确预测所造成预计支出与收益偏离实际的风险。企业经营风险是在经营过程中产生的,因此,经营风险贯穿于企业生产经营的全过程。     

同时存在导体和电介质的边界时电像法问题研究

讨论了导体与电介质同时存在情况下的电像法问题,指出了文献[1-2]中关于这一问题所出现的一些错误,并给出了正确的解答.     

基于EMD能量占比的海面漂浮小目标特征检测

针对传统的时频分析方法对海杂波分析有限的问题,提出一种基于经验模态分解(empirical mode decomposition,EMD)能量占比的海面漂浮小目标特征检测方法.首先,采用EMD将接收回波分为独立不同尺度的若干个固有模态(intrinsic mode function,IMF)分量,实现对接收回波的频率从...     

Blockage of the NLRP3 inflammasome by MCC950 improves anti-tumor immune responses in head and neck squamous cell carcinoma

The NLRP3 inflammasome is a critical innate immune pathway responsible for producing active interleukin (IL)-1β, which is associated with tumor development and immunity. However, the mechanisms regulating the inflammatory microenvironment, tumorigenesis and tumor immunity are unclear. Herein, we show that the NLRP3 inflammasome was over-expressed in human HNSCC tissues and that the IL-1β concentration was increased in the peripheral blood of HNSCC patients. Additionally, elevated NLRP3 inflammasome levels were detected in tumor tissues of Tgfbr1/Pten 2cKO HNSCC mice, and elevated IL-1β levels were detected in the peripheral blood serum, spleen, draining lymph nodes and tumor tissues. Blocking NLRP3 inflammasome activation using MCC950 remarkably reduced IL-1β production in an HNSCC mouse model and reduced the numbers of myeloid-derived suppressor cells (MDSCs), regulatory T cells (Tregs) and tumor-associated macrophages (TAMs). Moreover, inhibiting NLRP3 inflammasome activation increased the numbers of CD4⁺ and CD8⁺ T cells in HNSCC mice. Notably, the numbers of exhausted PD-1⁺ and Tim3⁺ T cells were significantly reduced. A human HNSCC tissue microarray showed that NLRP3 inflammasome expression was correlated with the expression of CD8 and CD4, the Treg marker Foxp3, the MDSC markers CD11b and CD33, and the TAM markers CD68 and CD163, PD-1 and Tim3. Overall, our results demonstrate that the NLRP3 inflammasome/IL-1β pathway promotes tumorigenesis in HNSCC and inactivation of this pathway delays tumor growth, accompanied by decreased immunosuppressive cell accumulation and an increased number of effector T cells. Thus, inhibition of the tumor microenvironment through the NLRP3 inflammasome/IL-1β pathway may provide a novel approach for HNSCC therapy.